Publications by authors named "Bruce Anthenat"

Compounding pharmacies, especially those awarded 503B status under the U.S. Federal Food, Drug, and Cosmetic Act that resulted from the Drug Quality and Security Act, must meet increasingly strict standards for the preparation of sterile formulations.

View Article and Find Full Text PDF

The safety and effectiveness of customized formulations have always been priorities for compounding pharmacists, perhaps even more so since a tragic outbreak of meningitis in 2012 was traced to preparations from the New England Compounding Center in Framingham, Massachusetts. Since that time, pharmaceutical compounding in the U.S.

View Article and Find Full Text PDF